HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kris De Clercq Selected Research

Lumpy Skin Disease

1/2022Assessment of the control measures for category A diseases of Animal Health Law: Lumpy Skin Disease.
12/2021A TaqMan probe-based multiplex real-time PCR method for the specific detection of wild type lumpy skin disease virus with beta-actin as internal amplification control.
10/2021Detection of Clinical and Subclinical Lumpy Skin Disease Using Ear Notch Testing and Skin Biopsies.
10/2021Review: Vaccines and Vaccination against Lumpy Skin Disease.
9/2021The Importance of Quality Control of LSDV Live Attenuated Vaccines for Its Safe Application in the Field.
5/2021Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines.
10/2020Complete Coding Sequence of a Lumpy Skin Disease Virus from an Outbreak in Bulgaria in 2016.
2/2020Lumpy skin disease epidemiological report IV: data collection and analysis.
1/2020An Immunoperoxidase Monolayer Assay (IPMA) for the detection of lumpy skin disease antibodies.
3/2019Risk of introduction of Lumpy Skin Disease into France through imports of cattle.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kris De Clercq Research Topics

Disease

14Lumpy Skin Disease
01/2022 - 11/2016
8Infections
10/2021 - 09/2004
5Foot-and-Mouth Disease
12/2018 - 01/2009
2Cattle Diseases (Bovine Diseases)
10/2021 - 10/2020
2Bluetongue
06/2012 - 01/2010
1Communicable Diseases (Infectious Diseases)
01/2019
1Virus Diseases (Viral Diseases)
11/2017
1Rhinitis
05/2014
1Coinfection
07/2013
1Vesicular Stomatitis
09/2004

Drug/Important Bio-Agent (IBA)

11Lysergic Acid Diethylamide (LSD)IBA
01/2022 - 11/2017
8VaccinesIBA
10/2021 - 01/2009
4Antiviral Agents (Antivirals)IBA
05/2014 - 09/2004
3RNA (Ribonucleic Acid)IBA
06/2012 - 09/2009
3Viral RNAIBA
06/2012 - 04/2008
2AntibodiesIBA
01/2020 - 04/2011
1Viral DNAIBA
10/2021
1ElementsIBA
12/2018
1Attenuated VaccinesIBA
11/2016
1Peptide Hydrolases (Proteases)FDA Link
03/2014
1Neutralizing AntibodiesIBA
07/2013
1Biological ProductsIBA
07/2013
1Indicators and Reagents (Reagents)IBA
06/2012
1CytokinesIBA
04/2011
1GTP Phosphohydrolases (GTPases)IBA
09/2004
1Interferon Type IIBA
09/2004

Therapy/Procedure

1Therapeutics
04/2008